127
Views
19
CrossRef citations to date
0
Altmetric
Review

Contemporary clinical management of atrial septal defects in the adult

, &
Pages 1135-1146 | Published online: 10 Jan 2014

References

  • Marelli AJ, Mackie AS, Msc RI, Rahme E, Pilote L. Congenital heart disease in the general population. changing prevalence and age distribution. Circulation115(2), 163–172 (2007).
  • Rigatelli G, Rigatelli G. Congenital heart diseases in aged patients: clinical features, diagnosis, and therapeutic indications based on the analysis of a twenty five-year Medline search. Cardiol. Rev.13, 293–296 (2005).
  • Bernier FP, Spaetgens R. The geneticist’s role in adult congenital heart disease. Cardiol. Clin.24, 557–569 (2006).
  • Webb G, Gatzoulis MA. Atrial septal defects in the adult: recent progress and overview. Circulation114, 1645–1653 (2006).
  • Ayres NA, Miller-Hance W, Fyfe DA et al. Indications and guidelines for performance of transesophageal echocardiography in the patient with pediatric acquired or congenital heart disease: report from the task force of the Pediatric Council of the American Society of Echocardiography. J. Am. Soc. Echocardiogr.18, 91–98 (2006).
  • Fredriksen PM, Veldtman G, Hechter S et al. Aerobic capacity in adults with various congenital heart diseases. Am. J. Cardiol.87, 310–314 (2001).
  • Hausmann D, Daniel WG, Mugge A, Ziemer G, Pearlman AS. Value of transesophageal color Doppler echocardiography for detection of different types of atrial septal defect in adults. J. Am. Soc. Echocardiogr.5, 481–488 (1992).
  • Munoz-Castellanos L, Espinola-Zavaleta N, Kuri-Nivon M, Ruiz JF, Keirns C. Atrial septal defect: anatomoechocardiographic correlation. J. Am. Soc. Echocardiogr.19, 1182–1189 (2006).
  • van den Bosch AE, Ten Harkel DJ, McGhie JS et al. Characterization of atrial septal defect assessed by real-time 3-dimensional echocardiography. J. Am. Soc. Echocardiogr.19, 815–821 (2006).
  • Marcu CB, Beek AM, van Rossum AC. Clinical applications of cardiovascular magnetic resonance imaging. CMAJ175, 911–917 (2006).
  • Weber OM, Higgins CB. MR evaluation of cardiovascular physiology in congenital heart disease: flow and function. J. Cardiovasc. Magn. Reson.8, 607–617 (2006).
  • Attie F, Rosas M, Granados N, Zabal C, Buendia A, Calderon J. Surgical treatment for secundum atrial septal defects in patients >40 years old. A randomized clinical trial. J. Am. Coll. Cardiol.38, 2035–2042 (2002).
  • Hein R, Buscheck F, Fischer E et al. Atrial and ventricular septal defects can safely be closed by percutaneous intervention. J. Interv. Cardiol.18, 515–522 (2005).
  • Attenhofer Jost CH, Connolly HM, Danielson GK et al. Sinus venosus atrial septal defect: long-term postoperative outcome for 115 patients. Circulation112, 1953–1958 (2005).
  • Shahriari A, Rodefeld MD, Turrentine MW, Brown JW. Caval division technique for sinus venosus atrial septal defect with partial anomalous pulmonary venous connection. Ann. Thorac. Surg.81, 224–229 (2006).
  • Salehian O, Horlick E, Schwerzmann M et al. Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects. J. Am. Coll. Cardiol.45, 499–504 (2005).
  • Hijazi Z, Wang Z, Cao Q, Koenig P, Waight D, Lang R. Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance: feasibility and comparison with transesophageal echocardiography. Catheter Cardiovasc. Interv.52, 194–199 (2001).
  • Zanchetta M, Onorato E, Rigatelli G et al. Intracardiac echocardiography-guided transcatheter closure of secundum atrial septal defect: a new efficient device selection method. J. Am. Coll. Cardiol.5(42), 1677–1682 (2003).
  • Rigatelli G, Hijazi ZM. Intracardiac echocardiography in cardiovascular catheter-based interventions: different devices for different purposes. J. Invasive Cardiol.18, 225–233 (2006).
  • Warinsirikul W, Sangchote S, Mokarapong P, Chaiyodsilp S, Tanamai S. Closure of atrial septal defects without cardiopulmonary bypass: the sandwich operation. J. Thorac. Cardiovasc. Surg.121, 1122–1129 (2001).
  • Kim JJ, Hijazi ZM. Clinical outcomes and costs of Amplatzer transcatheter closure as compared with surgical closure of ostium secundum atrial septal defects. Med. Sci. Monit.8, CR787–CR791 (2002).
  • Du ZD, Koenig P, Cao QL, Waight D, Heitschmidt M, Hijazi ZM. Comparison of transcatheter closure of secundum atrial septal defect using the Amplatzer septal occluder associated with deficient versus sufficient rims. Am. J. Cardiol.90, 865–869 (2002).
  • Doll N, Walther T, Falk V et al. Secundum ASD closure using a right lateral minithoracotomy: five-year experience in 122 patients. Ann. Thorac. Surg.75, 1527–1530 (2003).
  • Casselman FP, Dom H, De Bruyne B, Vermeulen Y, Vanermen H. Thoracoscopic ASD closure is a reliable supplement for percutaneous treatment. Heart91, 791–794 (2005).
  • Liang T, XiangJun Z, XiaoJing M, Yun L, Leng CY. New minimally invasive technique to occlude secundum atrial septal defect in 53 patients. Ann. Thorac. Surg.81, 1417–1419 (2006).
  • Butera G, Carminati M, Chessa M et al. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am. Heart J.151, 228–234 (2006).
  • Staniloae CS, El-Khally Z, Ibrahim R, Dore A, De Guise P, Mercier LA. Percutaneous closure of secundum atrial septal defect in adults a single center experience with the amplatzer septal occluder. J. Invasive Cardiol.15, 393–397 (2003).
  • Zanchetta M, Onorato E, Rigatelli G et al. Intracardiac echocardiography-guided transcatheter closure of secundum atrial septal defect: a new efficient device selection method. J. Am. Coll. Cardiol.42, 1677–1682 (2003).
  • Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart89, 199–204 (2003).
  • Butera G, Carminati M, Chessa M et al. CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects. Am. Heart J.148, 507–510 (2004).
  • Wang JK, Tsai SK, Wu MH, Lin MT, Lue HC. Short- and intermediate-term results of transcatheter closure of atrial septal defect with the Amplatzer Septal Occluder. Am. Heart J.148, 511–517 (2004).
  • Zanchetta M, Rigatelli G, Pedon L et al. Transcatheter atrial septal defect closure assisted by intracardiac echocardiography: 3-year follow-up. J. Interv. Cardiol.17, 95–98 (2004).
  • Post MC, Suttorp MJ, Jaarsma W, Plokker HW. Comparison of outcome and complications using different types of devices for percutaneous closure of a secundum atrial septal defect in adults: a single-center experience. Catheter Cardiovasc. Interv.67, 438–443 (2006).
  • Masura J, Gavora P, Podnar T. Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J. Am. Coll. Cardiol.45, 505–507 (2005).
  • Vida VL, Barnoya J, O’Connell M, Leon-Wyss J, Larrazabal LA, Castaneda AR. Surgical versus percutaneous occlusion of ostium secundum atrial septal defects: results and cost-effective considerations in a low-income country. J. Am. Coll. Cardiol.47, 326–331 (2006).
  • Silversides CK, Siu SC, McLaughlin PR et al. Symptomatic atrial arrhythmias and transcatheter closure of atrial septal defects in adult patients. Heart90, 1194–1198 (2004).
  • Roos-Hesselink JW, Meijboom FJ, Spitaels SE et al. Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21–33 years. Eur. Heart J.24, 190–197 (2003).
  • Brochu MC, Baril JF, Dore A, Juneau M, De Guise P, Mercier LA. Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation106, 1821–1826 (2002).
  • Giardini A, Moore P, Brook M, Stratton V, Tacy T. Effect of transcatheter atrial septal defect closure in children on left ventricular diastolic function. Am. J. Cardiol.95, 1255–1257 (2005).
  • Giardini A, Donti A, Formigari R et al. Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adults. J. Am. Coll. Cardiol.43, 1886–1891 (2004).
  • Giardini A, Donti A, Specchia S et al. Recovery kinetics of oxygen uptake is prolonged in adults with an atrial septal defect and improves after transcatheter closure. Am. Heart J.147, 910–914 (2004).
  • Veldtman GR, Razack V, Siu S et al. Right ventricular form and function after percutaneous atrial septal defect device closure. J. Am. Coll. Cardiol.37, 2108–2113 (2001).
  • Schussler JM, Anwar A, Phillips SD, Roberts BJ, Vallabhan RC, Grayburn PA. Effect on right ventricular volume of percutaneous Amplatzer closure of atrial septal defect in adults. Am. J. Cardiol.95, 993–995 (2005).
  • Attenhofer Jost CH, Oechslin E, Seifert B et al. Remodelling after surgical repair of atrial septal defects within the oval fossa. Cardiol Young. 12, 506–512 (2002).
  • Lopez K, Dalvi BV, Balzer D et al. Transcatheter closure of large secundum atrial septal defects using the 40 mm Amplatzer septal occluder: results of an international registry. Catheter Cardiovasc. Interv.66, 580–584 (2005).
  • Kong H, Wilkinson JL, Coe JY et al. Corrosive behaviour of Amplatzer devices in experimental and biological environments. Cardiol Young. 12, 260–265 (2002).
  • Ries MW, Kampmann C, Rupprecht HJ, Hintereder G, Hafner G, Meyer J. Nickel release after implantation of the Amplatzer occluder. Am. Heart J.145, 737–741 (2003).
  • Vida VL, Berggren H, Brawn WJ et al. Risk of surgery for congenital heart disease in the adult: a multicentered European study. Ann. Thorac. Surg.83, 161–168 (2007).
  • Krumsdorf U, Ostermayer S, Billinger K et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J. Am. Coll. Cardiol.43, 302–309 (2004).
  • Pees C, Haas NA, von der Beek J, Ewert P, Berger F, Lange PE. Cardiac troponin I is increased after interventional closure of atrial septal defects. Catheter Cardiovasc. Interv.58, 124–129 (2003).
  • Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc. Interv.63, 496–502 (2004).
  • Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J. Am. Coll. Cardiol.45, 1213–1218 (2005).
  • Therrien J, Warnes C, Daliento L et al. Canadian Cardiovascular Society Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease part III. Can. J. Cardiol.17, 1135–1158 (2001).
  • Care of the Adult With Congenital Heart Disease. Presented at: 32nd Bethesda Conference, Bethesda, MD, USA. 2–3 October 2000.
  • The Netherlands heart Foundation. Adult congenital heart disease in the Netherlands.Guidelines 2000. The Hague (2000).
  • Wren C, O’Sullivan JJ. Survival with congenital heart disease and need for follow-up in adult life. Heart85, 438–443 (2001).
  • Uebing A, Steer PJ, Yentis SM, Gatzoulis MA, Pregnancy and congenital heart disease. BMJ332, 401–406 (2006).
  • Hirth A, Reybrouck T, Bjarnason-Wehrens B, Lawrenz W, Hoffmann A. Recommendations for participation in competitive and leisure sports in patients with congenital heart disease: a consensus document. Eur. J. Cardiovasc. Prev. Rehabil.13, 293–299 (2006).
  • The Task Force on the Management of Grown Up Congenital Heart Disease of the European Society of Cardiology. Management of grown up congenital heart disease. Eur. Heart J.24, 1035–1084 (2003).
  • Sulica R, Poon M. Medical therapeutics for pulmonary arterial hypertension: from basic science and clinical trial design to evidence-based medicine. Expert Rev. Cardiovasc. Ther.3, 347–360 (2005).
  • Frost AE, Quinones MA, Zoghbi WA, Noon GP. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol. J. Heart Lung Trans.24, 501–503 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.